| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  BOOST Pharma Treating the untreatable BOOST Pharma is based on years of collaborative research from Karolinska Institute in Stockholm with the focus on novel cell therapy treatments for Osteogenesis Imperfecta. The research teams of associate professor Cecilia Götherström and professor Magnus Westgren have shown that that treatment with BOOST Cells greatly enhanced the quality of life for patients suffering from this otherwise extremely debilitating disease. Type: | 1 | 0 | 1 | 8 |
 |  ExpreS2ion Biotechnologies Innovative Vaccines for a Healthier World ExpreS2ion Biotechnologies is a clinical-stage DK based biotech company specialised in the development of new vaccines and immunotherapy products. The company has a discovery platform built around a proprietary recombinant expression system, ExpreS2 TM, developed especially for fast and efficient development and production of complex proteins required for innovative new vaccines, immunotherapy and diagnostics. The system also includes functionally modified glycosylation variants. For the clinical Phase III-stage COVID-19 vaccine, ABNCoV2, the Company employs a novel plug-&-play capsid virus-like particle (cVLP) platform, that offers competitive advantages in terms of long-term efficacy, safety, stability, and costing. … Type: | 1 | 0 | 1 | 21 |
 | PlaqueTec Ltd. Opening a new frontier in the fight against atherosclerosis PlaqueTec is pursuing a better understanding of the biological mechanisms of coronary artery disease (CAD) to advance the development of precision medicine. CAD, where atherosclerotic plaque build-up narrows or blocks the arteries that supply blood to the heart, is a leading cause of death globally. Current treatment approaches are one-size-fits-all and therefore ineffective for many patients. To address this, PlaqueTec has developed a proprietary technology and data analysis platform to endotype patients and uncover potential biomarkers of coronary vascular function and plaque progression. A more detailed understanding of patient endotypes will … Type: | 0 | 0 | 0 | 5 |
 | Guilford Street Laboratories At Guilford Street Laboratories (GSL), a UCL spin-out, we are dedicated to helping our clients achieve their research objectives. Leveraging machine learning-driven mass spectrometry, we deliver highly precise and sensitive biomarker panels, specializing in the analysis of protein, lipid, and metabolite markers. Whether your focus is on early disease diagnosis, drug discovery, collaboration as a partner in an EU Horizon consortium, clinical trials, or personalized medicine, our team is here to help. Mass Spectrometry, Biomarker, CRO, and Rare Disease Type: | 0 | 0 | 0 | 5 |
 | bit.bio The Cell Coding Company bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable … Type: | 0 | 0 | 0 | 208 |
 | LIfT BioSciences The world’s only alpha neutrophil cell therapy platform is being used to destroy all solid tumours. LIfT Biosciences is a biotech bringing to market a first-in-class alpha neutrophil cell therapy that overcomes the limitations of current therapies in solid tumours by destroying tumours both directly and indirectly. LIfT’s Immunomodulatory Alpha Neutrophils (IMANs) turn the tumour microenvironment against the tumour as they recruit the rest of the immune system to destroy the tumour to give a durable response and lasting immunity. The patented breakthrough N-LIfT platform is produced from a patented process using exceptional stem cells (iPSC or HSC), a proprietary … Type: | 1 | 0 | 1 | 23 |
 | Pheon Therapeutics Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs for a range of hard-to-treat cancers. Pheon Therapeutics is leveraging two decades of ADC experience to build a novel pipeline of next generation ADCs which offer the potential to treat solid tumors and liquid cancers that do not respond to other treatments. Understanding there is no “one size fits all” in engineering ADCs, Pheon takes a methodical approach to ADC development. Using both novel and clinically validated monoclonal antibodies (mAbs) and arming them either with warheads from their proprietary payload platform which boasts a novel mechanism of action or with … Type: | 1 | 0 | 1 | 23 |
 | BIOBank S.A. L'os humain préservé et régénéré BIOBank is a leader providing high-quality bone allografts to surgeons in orthopaedics, maxillofacial, and dental surgery. Our bone grafts are sourced from living donors in France & processed via our perfected Supercrit® technology, providing key advantages to surgeons and patients: - Total viral-inactivation - Maintainance of biomechanical and structural intergrity of the tissue - Availability in various shapes & forms, allowing easy handling during the surgical procedure - High quality bone integration, improving patient recovery BIOBank assure l’ensemble des activités d’une banque de tissus, de la prise en charge des tissus (recueil) à la délivrance … Type: | 1 | 1 | 0 | 39 |
 | Laevoroc Revolutionizing treatment for leukaemia relapse. Spearheading the development of a novel PNP inhibitor poised to revolutionize treatment for leukaemia patients facing relapse post-stem cell transplantation. Oncology Type: | 0 | 0 | 0 | 3 |
 | Locate Bio Ltd Reshaping rhBMP-2 Perspectives Relieving suffering and improving quality of life with next-generation orthobiologics. Regenerative Medicine, Biomaterials, Medical devices, Drug delivery, biotechnology, BMP2, Programmed Drug Release, and Instructive Tissue Scaffolds Type: | 0 | 0 | 0 | 24 |
 | Cellbox Labs Industrial organ on chip technology We are developing organs on a chip that are miniature organ replicas outside human body. We are focusing on microbiome and gut on on chip that allows to develop drugs more effective and study biological processes. We are also developing easy to use instrument to run experiments on the chips. Type: | 1 | 0 | 1 | 10 |
 |  YD Pharmaceuticals Patient focus YD Pharmaceuticals is a pharmaceutical company, with an EU-GMP certified indoor facility producing medical cannabis and distributing to EU Countries and other markets. With a 5,000m2 state of the art indoor facility located near Porto, YD Pharmaceuticals is strategically positioned to meet patient needs across all markets. Quality, stability, transparency and patient focus are YD Pharmaceuticals core values. | 0 | 0 | 0 | 1 |
 | Tandem Therapeutics Unlocking the matrix barrier to treat fibrotic diseases TANDEM Therapeutics is a discovery stage Swiss biopharmaceutical company bringing a novel precision targeting approaches to fibrosis and fibrotic cancers. We advance over 15 years of transformative research and development at ETH Zürich and Paul Scherrer Institut in the field of extracellular matrix biology and the critical role it plays in the pathology of fibrotic cancers & organ fibrosis. The therapeutic platform is based on Matrix Targeting Peptides (MTP) that conditionally target disease associated matrix alterations that are known to be directly associated with several fibrotic diseases. Type: | 0 | 0 | 0 | 5 |
 | Allegria Therapeutics Mastering Mast Cells Allegria Therapeutics was founded in Basel, Switzerland by Forty51 Ventures in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that selectively modulate mast cells, Allegria plans to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases. For more information, please visit www.allegriatx.com Mast Cell-Targeted Therapeutics, Allergy, and Inflammatory Disease Type: | 0 | 0 | 0 | 2 |
 | MarinaTex Developing a new material from seafood waste and algae, designed as a planet conscious alternative to plastic films. Type: | 0 | 0 | 0 | 4 |
 | Fuse Diagnostics Diagnostics. Simplified. Fuse develops and manufactures innovative diagnostic products for a range of industries delivering lab quality information wherever it is needed through ultra-rapid, low-cost tests. The immunoassay and PCR technologies that dominate the diagnostics industry have consistently failed to deliver lab-quality tests that are suitable for widespread decentralised use. Using an all-new multianalytic chemistry and breakthrough product innovations Fuse has overcome the cost and performance challenges of established approaches to make accurate, point-of-need testing a reality for all. Type: | 0 | 0 | 0 | 10 |
 | SynOx Therapeutics Our mission is to focus on the unmet clinical needs of patients suffering from Tenosynovial Giant Cell Tumours (TGCT) SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies. Type: | 0 | 0 | 0 | 18 |
 | Accession Therapeutics Limited Developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumour diversity Type: | 1 | 1 | 0 | 44 |
 | Commit Biologics A pioneer in the activation of the complement system to treat cancer and autoimmune disease. Commit Biologics (Commit) is a pioneer in activating the complement system to kill specific target cells, with applications in cancers and autoimmune diseases. Spun out of Aarhus University, and building on more than three decades of research, Commit’s Bispecific Complement Engaging (BiCETM) platform can supercharge a conventional monoclonal antibody to activate the complement system more effectively. This is achieved by combining single domain antibodies that engage C1q, the starting point for the complement activation cascade, with an antibody that binds to a cellular target. The … Type: | 0 | 0 | 0 | 20 |
 | Carbon Cell A carbon-negative, non-toxic, fully compostable replacement for polystyrene and other polymer-based foams. Carbon Cell is an expanded foam that reduces the need for conventional, fossil fuel-based foams while enabling significant carbon sequestration. Using biochar, a carbon-negative material sourced from biomass that would otherwise be burned or decomposed, we have created a high-performance, non-toxic, expandable, fully biodegradable foam. Carbon Cell has a renewable supply chain composed of organic waste and, because it is biodegradable and non-toxic, it can be reintegrated into the biosphere at end of life. Carbon Cell leverages the inherent properties of biochar – non-toxic, highly porous, lightweight, large … Type: | 2 | 0 | 2 | 7 |
 | Adaptimmune Designing and delivering cell therapies to transform the lives of people with cancer. Adaptimmune is a fully integrated cell therapy company, designed and built from the ground up with four U.K.- and U.S.-based biotechnology hub locations. Our comprehensive capabilities and teams include preclinical research, clinical development, translational sciences, autologous and allogeneic manufacturing, and in-house commercial and corporate operations. For more information about Adaptimmune, please visit www.adaptimmune.com. If interested in joining our fast growing team, click on the careers tab of this page. Type: | 0 | 0 | 0 | 537 |
 | Cognivia Developing predictive tools to de-risk clinical drug development Cognivia is an innovator of analytical tools to optimize and accelerate the clinical development of new medicines. The privately held company was founded in 2013 by longtime colleagues with decades of experience in the pharmaceutical industry who set out to tackle some of the most challenging issues that prevent drugs from reaching the marketplace. Cognivia helps lessen risk and helps increase clinical trial success. It can help reduce the variability of study data by 30 percent. This can lead to fewer patients needed in a study, equating to less cost and time. … Type: | 2 | 1 | 1 | 25 |
 | Monument Therapeutics Bringing Precision Medicine to Neuroscience Drug Development Monument Tx is an independent UK based biotechnology company formed as a spin-out from Cambridge Cognition in 2021. Monument Tx develops products to treat serious diseases of the central nervous system. Our precision medicine approach utilises proprietary digital biomarkers to reduce heterogeneity and identify patients with homogenous underlying neurobiology, which are then matched with appropriately targeted compounds. Using biomarkers to more accurately identify patients with a disease sub-type most likely to respond to a particular treatment is already successfully used in the treatment of cancer. Now Monument Tx brings digital biomarkers to neuroscience … Type: | 0 | 0 | 0 | 6 |
 | SmartCatch For a reliable liquid biopsy accessible to everyone Precision medicine is the adaptation of a medical treatment to the exact molecular profile of each patient. More generally, it relies on the sophisticated analysis of circulating biomarkers (genetic, protein or cellular) in the blood flow of patients. SmartCatch arises from a research work initiated in 2012 by a team of multidisciplinary scientists from the Laboratory of Analysis and Architecture of Systems (LAAS, CNRS) and urologist surgeons of the IUCT-Oncopole and Toulouse hospital. The results of this work have been patented in February 2015. Carried by four of its inventors, SmartCatch was … Type: | 16 | 5 | 13 | 20 |
 | CrocosGoDigital [Automatic translation follows] AI for cognitive stimulations for kids by coding robots/drones/..., and brain dysfunctions detection. CrocosGoDigital is a start-up specialized in Neuro-Education for children 6-12 years old and seniors - use of neuroscience and AI for a new generation of training in Programming robots, drones, AI engines, ... The objective is to boost/stimulate the cognitive functions of children and seniors, whatever their level, precocious or with learning difficulties, to make them progress at their own pace through motivation. This is why our training is 'adaptive', and designed to stimulate cognitive functions. Ultimately, with our partners in Neuroscience and our … Type: | 22 | 9 | 3 | 10 |
 | Antofénol [Automatic translation follows] Our vision: Obtain the best of the plant, without using conventional chemical solvents. Our know-how: - Simultaneously exploit 4 proven eco-extraction technologies. - Provide solutions for the development of your ingredients in order to enrich your range of active biomolecules (polyphenols, flavonoids, alkaloids) Our objective: Offer eco-responsible solutions to enable you to meet the ecological and economic challenges of the future. vacuum distillation, plant eco-extraction, R&D, objective ingredients, microwaves, ultrasound, atomization, freeze-drying, grinding, natural extracts, active ingredient, 100% natural active ingredients, eco-responsible, polyphenols, essential oils, cosmetics, perfumery, nutraceuticals, and agri-food Type: | 14 | 7 | 8 | 19 |
 | Kiro Artificial intelligence serving clinical biology Kiro is a fast-moving startup developing solutions for better patient care, powered by artificial intelligence. We aim at improving everyone’s health by supporting patients and doctors with understandable and relevant information. We believe that medical biology is at the heart of healthcare. It contributes greatly to the diagnosis, treatment and prevention of diseases. Our mission is to foster the interactions between laboratories, health professionals and patients, to go beyond results in patient care thanks to new technologies and artificial intelligence. Since its inception, Kiro has worked in close partnership with clinical biologists, doctors and medical … Tags: FrenchTech2030 Type: | 48 | 13 | 23 | 58 |
 | MicroOmix We give access to the pulse of life Unlocking the Future of Cell Screening with Groundbreaking Innovation MicroOmix is a pioneering startup powered by patented technology from the CNRS and the University of Strasbourg, setting a new standard in high-throughput cell screening. Our cutting-edge platform analyzes cells based on the molecules they secrete, with a level of precision and resolution that is unrivaled. Secreted molecules are at the heart of critical biological processes—driving immune responses, cell migration, tissue regeneration, and differentiation. Emerging research reveals their pivotal role in disease progression and therapeutic effectiveness, but until now, accessing these insights has … Type: | 4 | 2 | 0 | 4 |
 | LiveDrop Bio We create all-in-one instruments that make high-throughput single-cell workflows easy thanks to droplet microfluidics LiveDrop is a pioneering tech firm dedicated to establishing groundbreaking benchmarks in the realm of delicate, high-throughput, precise droplet biology. Embark on a journey with us to explore the potential for your own projects through Calendy: https://calendly.com/francois-dohet/let-s-bring-things-forward Introducing ModaFlowTM, an innovative suite of high-precision, high-throughput 3-in-1 integrated instruments designed for Research and Development, as well as the Industrialization of droplet bio-assays, spanning from culturomics to potency assays. This platform allows for extensive customization of both the optical components and software control. Specifically tailored for executing straightforward … Type: | 2 | 2 | 1 | 14 |
 | Marseille Immunology Biocluster Marseille Immunology Biocluster, where the future of Immunology comes to life. 🎓 Marseille Immunology Biocluster (MIB) is a project aiming to strengthen France’s influence in healthcare. 🧬 Led by Aix-Marseille University and involving over 20 partners (Big Pharma, biotech, research entities, hospitals, technology transfer entities, local authorities ...) it is backed by a €96 million budget under the France 2030 government initiative to advance immunotherapy drug development. 🤝 Located in the heart of Marseille, a city with over 40 years of immunology research history, MIB's mission is to foster and expand cooperation among all players in shaping the future of … Type: | 10 | 3 | 6 | 1 |
 | CancerTools.org (CancerToolsOrg) A global cancer community, where researchers contribute and access research tools to accelerate cancer research. CancerTools.org is a non-profit, global community of cancer researchers, academic institutes and societies, with a shared mission, to accelerate cancer research discoveries. In this collaborative, researchers contribute research tools and share knowledge to deepen our understanding of cancer, and drive innovation within cancer research. CancerTools.org shares a mission with cancer researchers to accelerate cancer research. To that end, tools accessed through CancerTools.org pay for future cancer research, via a global revenue share to the inventing researcher and to Cancer Research UK, the world’s largest cancer … Type: | 1 | 0 | 0 | 31 |
 | European Society for Molecular Imaging - ESMI The ESMI represents an international, academic community of imaging scientists with a strong multidisciplinary focus. The European Society for Molecular Imaging represents and advocates “IMAGING SCIENCE” as an important resource for the development of new imaging technologies, as a motor for advancing innovative methodological concepts to validation studies as well as supporting the translational process of taking innovation into the clinical environment. ESMI represents an international, academic community of imaging scientists. The ESMI serves the basic imaging science community and clinical subspecialties focusing on experimental research using imaging modalities and stimulates interdisciplinary research. Central to the mission of ESMI is … Type: | 1 | 1 | 0 | 9 |
 | ARTiDe ARTiDe aims to generate an antigen-specific cellular therapy for type 1 diabetes for a future clinical trial. Autoantigen-specific Regulatory T cell therapy against Type 1 Diabetes (ARTiDe) will make a unique contribution to the understanding of autoimmunity in humans and the development of antigen-specific immunotherapy. ARTiDe has the ambition to take the lead in the restoration of long-lasting immune tolerance in Type 1 Diabetes (T1D) patients, aiming to provide a cure for this disease. Type: | 1 | 1 | 0 | N/A |
 | Skinosive Innovation in Skin Health Skinosive is a science-driven dermo-cosmetics biotechnology company developing a technology platform in skin photoprotection. Skinosive’s technology enables long-acting skin UV protections and effective sunscreens that prevent chemicals from being absorbed into the skin and the bloodstream. This innovation aims to reduce drastically cancer and skin damages due to the sun exposure. The company is located in Paris and in Marseille. Skinosive Headquarter : 12-14 rue Jean Antoine de Baïf 75013 Paris Skinosive Lab : 60 avenue André Roussin 13016 Marseille | 2 | 2 | 1 | 14 |
 | Perfood Prescription digital therapeutics powered by personalized nutrition. Reimagining medicine At Perfood, we translate state-of-the-art data and medical science into therapy. We create software, that precisely identifies what actions need to be take on a personalized level, to prevent or fight diseases. Using sensors, lab results and holistic analyses, we derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. We call this approach digital therapeutics. A digital solution that is just as effective as a drug. But without side effects. We believe that our genetic heritage is an elementary compound of our health. … Type: | 2 | 2 | 0 | 100 |
 | Cline Research [Automatic translation follows] When patients meet clinical research. Cline Research is a clinical research start-up, incubated at iPEPS at the ICM, whose mission is to open clinical research to patients and physicians to make clinical trials accessible and accelerate the marketing of new therapies. We are developing the Cline platform to accelerate recruitment on clinical trials. Cline is available to patients, investigating and referring physicians, and clinical trial sponsors. clinical research and clinical trials Type: | 5 | 1 | 5 | 2 |
 | SABER BIO Deep characterization of each single cell to accelerate life science research. SABER BIO is developing benchtop instruments for deep characterization of each single cell to accelerate life science research. Our instruments are based on ultra high throughput droplet-based microfluidics (up to 10 million cells) to perform functional single cell screening. In addition, our instruments enable the linkage of phenotype and genotype information on a single cell resolution. SABER, Single cell Analysis by Enhanced Resolution Single cell analysis , droplet microfluidics, high content imaging, functional cell sorting, and high throughput screening Type: | 2 | 2 | 0 | 17 |
 | Mission Lucidity Engineers, scientists and clinicians transforming neurodegeneration research, paving the way for prevention and cures. Mission Lucidity is an interdisciplinary partnership between imec, KU Leuven, UZ Leuven and VIB. By building bridges between clinicians, scientists and engineers, we are creating transformative scientific and medical solutions for neurodegenerative diseases, paving the way for prevention and personalized treatments. Type: | 1 | 1 | 0 | 2 |
 | CARLA Biotherapeutics First In Class Adoptive Cell Therapies to Cure Patients Carla Biotherapeutics is a Biotech company developing first-in-class adoptive cell therapies tailored to treat diseases with high unmet medical need with a first focus on aggressive life-threatening cancer. Carla Biotherapeutics is founded by a team of seasoned clinicians, cell therapy scientists and biotech professional in Besançon, France with access to a world-class and unique cell-therapy platform. Carla Biotherapeutics’ ambition is to build and develop a pipeline of immunotherapies based on a fully integrated cell therapy platform to discover ena develop adoptive cell therapies tailored to each indication. Type: | 9 | 1 | 8 | 2 |
 | European Society of Gene and Cell Therapy ESGCT is a non-profit educational and scientific organisation in the field of gene and cell therapy. The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional adviser to stakeholder communities and regulatory bodies in Europe. Gene Therapy, Cell Therapy, Research, Medicine, Biotechnology, Genome Editing, Gene editing, and CRISPR Type: | 2 | 1 | 0 | 9 |
 | Mission Massimo Foundation The Mission Massimo Foundation is a non-profit organisation that promotes the prevention, diagnosis and treatment of childhood leukodystrophies. These are a group of life-threatening genetic conditions that affect the formation of myelin, a complex fatty substance that acts as an insulator, around nerve fibres in the brain much like electrical wiring. Our aim is to accelerate the discovery of genetic variations responsible for childhood leukodystrophies and to translate these into clinical trials and treatments. Medical Reseaarch, Leukodystrophies, Genomics, Stem Cell Therapies, and Gene Therapies Type: | 3 | 1 | 3 | 3 |
 | Breast Cancer Prevention Partners (BCPP) Exposing the cause is the cure For over 30 years, we have been the leading science-based policy and advocacy organization working to prevent breast cancer by eliminating our exposure to toxic chemicals. Our focus is on the intersection of breast cancer prevention and environmental health. Type: | 15 | 0 | 14 | 26 |
 | GO2 for Lung Cancer Leading the charge to confront lung cancer relentlessly on every front, every day, for everyone. GO2 for Lung Cancer is at the forefront of everything that’s happening in lung cancer. We’re the go-to for one-on-one assistance, supportive connections, treatment information, and finding the best care close to home. We’re the place to go to learn about the latest research and special initiatives that increase survivorship. We’re the source for improving health policies and leading public awareness to shift this disease from one of stigma to one of hope. We are teachers, guides, advocates, and supporters. Confronting lung cancer starts here. … Type: | 12 | 4 | 11 | 65 |
 | Ripack - Groupe Sefmat La Protection par Excellence In 1922, RIPPES begins its activity by producing flame welding equipment. In 1975 the idea of covering a loaded pallet with a heat shrink cover in order to stabilise the load and offer weather and theft protection, was hatched and rapidly expanded. The RIPPES Company was one of the first to develop a 'gun' connected to a gas supply, which, by dint of its hot flame, shrunk these shrink wrap covers. The rapid expansion of demand for these shrink 'guns' led to the company setting up a new corporate entity in 1981; the SEFMAT company, with … Type: | 1 | 1 | 0 | 15 |
 | HP2 LABORATOIRE To investigate the influence of hypoxia, sleep and exercise on cardiometabolic health trajectories Our goal is to investigate the influence of hypoxia, sleep and exercise on cardiometabolic health trajectories with molecular, pathophysiological and epidemiological approaches. HP2 LABORATOIRE is a research Inserm unit based out of Grenoble Alpes Univeristy and Grenoble Alpes University hospital, France. The future of medicine relies on the ability to assess disease risk at an individual level, understand molecular mechanisms underlying progression of disease and aggregation of comorbidities and early initiation of personalized interventions. To achieve this goal of precision and personalized medicine in obstructive sleep apnea … Type: | 5 | 4 | 2 | 33 |
 | EKIUM COME TO EXPRESS YOUR TALENT THROUGH OUR AMBITIOUS PROJECTS EKIUM continues its development in France and abroad in the fields of industrial and building Engineering and Automation. We are committed as a partner with the leaders of the chemical, pharmaceutical, energy, oil & gas, aeronautics, food processing industry... Today we are 1200 women and men, experts and enthusiasts. Would you like to join our Ekip * (Ekium Identity Project)? charges.recrutement@ekium.eu We offer jobs in our 25 national offices and abroad (Benelux & Mauritius). industrie, énergie, naval, nucléaire, chimie, and pharmaceutique Type: | 41 | 10 | 22 | 1,439 |
 | Advanced Accelerator Applications We are your partner of choice in Europe for precision diagnostic solutions for positron emission tomography (PET) imaging – a cornerstone of personalized nuclear medicine. Our core mission is to develop, manufacture, test, and timely supply radiopharmaceutical products for patients in need, with a primary focus on oncology, while expanding our network and expertise into other disease areas, such as neurology, as we continue to unlock the potential of molecular imaging in nuclear medicine. Type: | 4 | 2 | 1 | 833 |
 | ProteoGenix Accelerate your way to the clinic ProteoGenix is a leading life sciences organization which provides services in molecular biology and immunology and in particular polyclonal and monoclonal antibody development, recombinant protein expression and purification, peptide synthesis as well as gene synthesis. ProteoGenix’s commitment to its clients is to ensure the access to comprehensive and integrated solutions to help our customers develop the tools they need to efficiently conduct their biology and research projects in a time effective manner. Beginning with the synthesis of the gene ProteoGenix develops all the materials required for immunoassay services. Proteogenix’s exceptional and functional expertise combined … Type: | 1 | 1 | 0 | 42 |
 | Drugabilis CRO specialized in pharmaceutical drugability for research Expertise in Human and Animal health solid form characterization and formulation development. We deliver both experimental support and consulting services to biotechnology and pharmaceutical companies, not-for-profit organizations and complementary CROs. We are member of the association AFSSI, 1st French research center in Life Sciences, as a founding member and member of the board of Directors. Since March 2019 Joel Vacus, Drugabilis CEO & CSO, is vice-President of AFSSI. https://www.afssi.fr/ Feel free to contact us in order to exchange about your preclinical drug development! contact@drugabilis.com Lead optimization, Formulation, and Physical form optimization Type: | 1 | 0 | 1 | 7 |
 | DIVERCHIM CDMO API manufacturer of small quantities and GMP excipients supplier Founded in 2000, DIVERCHIM is the leading French company for organic synthesis of original molecules bringing its customers a top level expertise. DIVERCHIM is a Contract Research Organisation (CRO) in organic chemistry. Our teams combine experience in drug discovery and process development, medicinal chemistry, parallel synthesis, biochemical tools and fine chemicals to deliver you with unique chemistry solutions to achieve your requirements. Diverchim specifies in complex multi-steps synthesis, low temperature chemistry, asymmetric, organometallic, cyclopropane, pyrrolidine, oxetane chemistry... Besides Diverchim can scale-up existing processes or develop a new process for existing products. … Type: | 4 | 2 | 4 | 49 |
 | Institut Pasteur The Institut Pasteur, a non-profit foundation with recognized charitable status set up by Louis Pasteur in 1887, is today an internationally renowned center for biomedical research with a network of 33 members worldwide. In the pursuit of its mission to tackle diseases in France and throughout the world, the Institut Pasteur operates in four main areas: research, public health, training, and development of research applications. The Institut Pasteur is a globally recognized leader in infectious diseases, microbiology, and immunology, with research focusing on the biology of living systems. Among its areas of investigation are emerging infectious diseases, antimicrobial resistance, certain … Type: | 106 | 62 | 46 | 4,160 |
 | BIOASTER Disrupting Healthcare - De-risking Innovation - Transforming Technologies BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to : -Fight antimicrobials resistance. -Improve vaccines safety and efficacy. -Quickly diagnose infections at patient bedside. -take full advantage to human and animal microbiota. In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around key thematic and technology units. Each project strives on academic research excellence and is undertaken by a team of … Type: | 33 | 10 | 22 | 115 |
 | Yposkesi, an SK pharmteco company Partnering to bring your cell and gene therapies to life! ***This page has moved and is no longer active. Please follow us @SK pharmteco for all company news and updates.*** Yposkesi, an SK pharmteco company, is one of Europe’s largest Contract Development and Manufacturing Organizations (CDMO) for gene therapy viral vector manufacturing. As a trusted partner for biotech and pharmaceutical companies seeking to advance clinical trials and commercialize new Advanced Therapy Medicinal Products (ATMPs), Yposkesi offers a full range of services in lentiviral vectors and AAV (Adeno-Associated Virus) cGMP manufacturing. Within its current 50,000 ft2 (approx. 5,000 m2) facility, Yposkesi … Type: | 18 | 4 | 15 | 168 |
 | Neurinnov Neurinnov is a company based out of Montpellier, Occitanie, France. Our aim is to restore human functions in people with functional deficiencies for better quality of life Type: | 9 | 3 | 2 | 14 |
 | I4ID Congress Immunotherapies & Innovations for Infectious Diseases (I4ID) Congress - November 22-23, 2023 - Lyon IMMUNOTHERAPIES & INOVATIONS FOR INFECTIOUS DISEASES CONGRESS immunotherapy, infectious Diseases, Congress, Innovation, Industry, Drug Discovery, Therapy, B2B, Networking, diagnostic, and vaccines Type: | 19 | 2 | 19 | N/A |
 | CRBM - CNRS Internationally recognized research in molecular and cellular biology The Centre de Recherche en Biologie cellulaire de Montpellier (CRBM) is an international, non-profit, and interdisciplinary research center. We are supported both by the French National Center for Scientific Research (CNRS) and the University of Montpellier. At the CRBM, we use modern approaches to address fundamental questions in biochemistry and cell biology, using a wide range of model organisms. We also translate our findings to biomedical research, to better understand the molecular basis of diseases and to develop innovative therapeutic strategies. Our research is facilitated by several outstanding services and platforms, including … | 16 | 0 | 10 | 67 |
 | IARC - International Agency for Research on Cancer / World Health Organization The International Agency for Research on Cancer (IARC) is the cancer agency of the World Health Organization Official LinkedIn page of the International Agency for Research on Cancer, the cancer research agency of the World Health Organization. IARC's mission is to coordinate and conduct research on the causes of human cancer, the mechanisms of carcinogenesis, and to develop scientific strategies for cancer prevention and control. The Agency is involved in both epidemiological and laboratory research and disseminates scientific information through publications, meetings, courses, and fellowships. Support cancer prevention research http://isupport.iarc.fr IARC alumni are invited to join the IARC Alumni Group … Type: | 20 | 7 | 11 | 428 |
 | AFCROs Les entreprises de la Recherche Clinique 🇫🇷 The French Association of CROs (Association Française des CROs or “AFCROs”) was established in 2002 in order to represent clinical and epidemiological research organizations, headquartered or operating in France, that provide services to the pharmaceutical and medical device sectors. Its purpose is to maintain a dialogue with French health authorities and institutions, patient associations and the industry and at a European level with EUCROF on the role of CROs within the context of clinical development of healthcare products. Essais cliniques, Pharmaco-épidémiologie, Etudes Observationnelles, Données de santé en vie réelle, Economie de la Santé, … Type: | 17 | 4 | 13 | 8 |
 | EUROGIN Conference EUROGIN is the world’s leading international congress on HPV infection and associated cancers. EUROGIN is the world's leading international congress on HPV infections and associated cancers with a focus on prevention and diagnostics. The event aims at translating scientific and evidence-based research into clinical practice through its high-quality and innovative program drawn up by outstanding international leaders. The conference offers a forum to exchange knowledge and experience with peers from all over the world. Human Papilloma Virus (HPV), Head and Neck Cancers (HNC), International HPV Congress, and Continuing Medical Education (CME) Type: | 0 | 0 | 0 | 2 |
 | Axoltis Pharma The CNS Regeneration Company Axoltis pharma is a biopharmaceutical company dedicated to develop a first-in-class disease-modifying drug to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs. Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders. Our products are first-in-class multifunctional peptides with high potential in many CNS disorders. neurodegenerative diseases, neurodegeneration, spinal cord injury, peptide, neuroprotection, neural repair, regeneration, drug, biotechnology, pharma, CNS, neurology, ALS, Parkinson, and Multiple Sclerosis Type: | 4 | 2 | 2 | 13 |
 | Kairos Biotech Ltd R&D company focusing on transplant theranostics. Research and development of transplant diagnostics and immunotherapy solutions targetting transplantation tolerance. | 0 | 0 | 0 | 6 |
 | VitroLabs Inc Harnessing science and nature to cultivate authentic materials starting with slaughter-free cultivated leather. We cultivate authentic materials without compromise,by harnessing science and nature responsibly by partnering the most innovative minds in science and technology with the finest craftspeople to accelerate the use of cellular agriculture for good. Our first product is slaughter-free, real leather. cellular agriculture, tissue engineering, leather, luxury leather, lab-grown, cultivation, Bioprocessing, and bioreactor Type: | 3 | 2 | 1 | 16 |
 |  Immune Design | 0 | 0 | 0 | 58 |
 | Avalon AI Avalon AI builds Deep Learning-based Computer Aided Diagnosis tools to facilitate the detection of brain degenerative diseases like Alzheimer's and enable better patient stratification in clinical trials. Deep Learning, Machine Learning, Medical Imaging, MRI, Neuroimaging, Neuroscience, Software Engineering, Neural Networks, Computer Aided Diagnosis, and Artificial Intelligence Type: | 3 | 1 | 1 | 1 |
 | Hemogenyx Pharmaceuticals Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in New York City at its state-of-the-art research facility. The Company is a clinical-stage biopharmaceutical group developing new medicines and treatments for life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development. | 1 | 0 | 0 | 9 |
 | Science Creates Science Creates is a deep tech ecosystem that enables scientists and engineers to build disruptive businesses. Science Creates believes that deep tech startups are society's most effective economic vehicle to deliver innovation and global impact for the health of people and the health of our planet. We empower, support and inspire people over three decades of their journey in becoming world leading deep tech founders. Our growing network of scientific startups are solving global problems with groundbreaking advancements in healthcare, the environment and quality of life. We have two research facilities in Bristol, a venture capital arm that offers investment … Type: | 7 | 0 | 7 | 19 |
 | Asahi Kasei Bioprocess America, Inc. Pioneering Biologics Safety and Manufacturing Efficiency As a global partner to the biopharmaceutical industry, Asahi Kasei Bioprocess helps biologics manufacturers safely and efficiently produce medicines that patients can trust, by dependably supplying innovative yet exceptionally reliable bioprocess consumables, equipment and scientific support services. Our portfolio is anchored by PlanovaTM virus removal filters. First released in 1989 as the world's first hollow fiber filter developed specifically for removing viruses from biotherapeutic drug products, PlanovaTM filters ensure viral safety of biopharmaceutical drug products, thanks to their high quality and consistent performance. Leveraging 30 years of experience, we continue to provide our customers … Type: | 0 | 0 | 0 | 125 |
 | Maze Therapeutics At Maze, we envision a world where genetic insights inspire new medicines. Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. Advances in these areas have enabled us to decode the mysteries of genetic modifiers in a range of severe diseases, which we aim to turn into medicines that mimic protective mutations. We have assembled a world-class team that we need to realize this vision, including creative scientific pioneers in genetics, experienced company builders, and biotech industry leaders. Type: | 1 | 0 | 1 | 129 |
 | Tetra Therapeutics, a SHIONOGI Group Company Follow us at Shionogi Inc. for news about our rare disease research programs https://www.linkedin.com/company/shionogi-inc-/ drug discovery, PDE4D, PDE4B, Fragile X, CTE, Rubinstein-Taybi, traumatic brain injury, Clinical Trials, Fragile X syndrome, Cognition, BPN14770, and Memory Loss Type: | 1 | 1 | 0 | 6 |
 | Qpex Biopharma Focusing on Resistance in Antibiotic Development Qpex Biopharma, Inc. a Shionogi Group Company, is a resistance-focused infectious disease company on a mission to make both a dramatic and sustainable improvement in patient care. Leveraging a multi-faceted approach and a deep understanding of drug resistance mechanisms, we are creating novel products and development. strategies that overcome multi-drug resistance. We are advancing a robust portfolio of treatments that will bring innovation to antibiotic development and deliver the right treatments to the right patients in the right settings. During the previous decade, our team brought 4 antibiotic products to regulatory approvals, with an … Type: | 1 | 1 | 1 | 26 |
 | Apnimed Apnimed is a clinical-stage company advancing oral medicines to treat Obstructive Sleep Apnea and related disorders. Apnimed is a clinical-stage company focused on advancing oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders. sleep medicine and Obstructive Sleep Apnea | 1 | 1 | 0 | 75 |
 | Kelonia Therapeutics Revolutionizing in vivo gene delivery to usher in a new era of genetic medicines. Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform. The company’s simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. With an initial focus on developing transformational therapies for solid tumors and hematologic cancers, Kelonia is building a pipeline of genetic medicines for a wide range of diseases, with the bold goal … Type: | 2 | 1 | 1 | 61 |
 | CellSine Discover your favorite frequencies to boost your drug discovery business CellSine provides devices and software that make advanced electrochemical impedance spectroscopy easily accessible to any microbiological researcher. It delivers a platform tool for a that enables a wide variety of biochemical studies. Biotechnology, Cell culture monitoring, Proteïn - Proteïn interactions, Suspension cultures, Receptor signaling, Biofilm maturation, and T lymphocyte activation Type: | 1 | 1 | 0 | 4 |
 | mindtrace | 3 | 0 | 3 | N/A |
 | Tetratherix Tetratherix has developed the first biostealth fluid matrix to disrupt regenerative medicine and targeted mRNA delivery. Tetratherix has developed a proprietary fluid matrix that is invisible to the body & does not induce any foreign body reaction to evolve regenerative medicine and targeted therapeutic delivery. Tetramatrix is a water based polymer solution that forms an adhesive hydrogel once administered to the body. The product is fully synthetic, biocompatible and resorbable. After a decade of development with meticulous polymer programing, Tetratherix is advancing the world of biopolymers by developing real world applications specific to multiple indications in an effort to change … Type: | 0 | 0 | 0 | 12 |
 | Precision Medicine Scotland Innovation Centre We bring together innovators, clinicians and researchers to facilitate the adoption of Precision Medicine in Scotland. Welcome to Precision Medicine Scotland’s home on LinkedIn. Follow us for updates on collaboration opportunities, funding news and the latest updates on Scotland’s advances in Precision Medicine. Precision Medicine Scotland Innovation Centre (PMS-IC) enables the development of new products and services for a global market. PMS-IC is an Innovation Centre that brings together industry innovators, clinicians and world-class researchers to collaborate on precision medicine opportunities. Our focus is on linking Scotland’s domain expertise, data assets and world-class delivery infrastructure to accelerate the adoption of … Type: | 4 | 0 | 4 | 6 |
 | Integrated Micro-Chromatography Systems A leader in recombinant enzymes and automated micro-chromatography technologies About Integrated Micro-Chromatography Systems, Inc. At Integrated Micro-Chromatography Systems (IMCS), we strive to address the growing needs of clinical and research laboratories through advanced technologies that increase testing efficiency. IMCS products help to drive the future of precision medicine. We understand the importance of accuracy, which is why we are committed to delivering products that consistently provide fast, reliable results. Company History Integrated Micro-Chromatography Systems, Inc (IMCS) was founded in January 2013 by three scientists from the University of South Carolina. IMCS designs, develops, manufactures, and distributes next-generation recombinant proteins and … Type: | 1 | 0 | 1 | 35 |
 | Ossium Health The Greatest Wealth is Health® Our mission is to improve the health, vitality, and longevity of human beings through bioengineering. Who we are: At Ossium, we believe that science is humanity’s best weapon in the fight against disease, and we embrace the challenge of mobilizing the world’s healthcare ecosystem to win that fight. In pursuit of this goal, we empower our employees, maintain the highest standards of excellence, and are a force for good. Values we live by: Impact We are mission-driven and results-oriented. We believe that a healthier world is a better one and that our work should drive … Type: | 2 | 0 | 2 | 93 |
 | Cyclica (acquired by Recursion, Nasdaq: RXRX) From molecule to medicine Unlocking the protein universe to discover the medicines of tomorrow Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter. Drug Development, Network Pharmacology, Drug Repositioning, Proteomics, Clinical Trials, Side Effects, Bioinformatics, Systems Biology, Drug Discovery, Artificial Intelligence, polypharmacology, medicines, Machine learning, pharmacology, pharmaceuticals, and bioinformatics Type: | 20 | 3 | 13 | 4 |
 | PDC*line Pharma A novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line (PDC*line) Founded in 2014 as a spin-off of the French Blood Bank (EFS), PDC*line Pharma is a French-Belgian biotech company that develops an innovative class of active immunotherapies to treat cancers. This cancer vaccine contains proprietary, potent, and scalable plasmacytoid dendritic cell line (PDC*line), whose remarkable characteristics make them excellently suited for immunotherapy. PDC*line is much more potent to prime and boost antitumor antigen, including neoantigens, specific cytotoxic T-cells than conventional vaccines and improves the response to checkpoint inhibitors. PDC*line offers unique advantages: - PDC*line … Type: | 13 | 3 | 7 | 25 |
 | BioNTech SE Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases. BioNTech is a global next generation immunotherapy company aspiring to translate science into survival. Around 6.100 pioneers currently work with us, employing a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Our broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor (CAR) T cells, several protein-based therapeutics, including bispecific immune checkpoint modulators, targeted cancer antibodies and antibody-drug conjugate (ADC) therapeutics, as well as small molecules. … Type: | 41 | 19 | 9 | 4,851 |
 | Creativ-Ceutical Creativ-Ceutical provides strategic pricing, market access and health economics consulting in life sciences. We provide both the strategic advice and the technical services to deliver results that meet your expectations. We have broad experience in the areas of central nervous system (CNS), oncology, vaccines, metabolic/cardiovascular diseases, and rare diseases. These are complex and developing fields, where treatment paradigms are in constant evolution and where clinical and economic issues require rigorous analysis to determine the best therapeutic choices. This experience allows us to address the most complex challenges and to anticipate pricing and market access issues that will arise in other … Type: | 0 | 0 | 0 | 83 |
 | Venn Life Sciences - part of hVIVO plc Integrated Drug Development from Discovery to Market - Part of the hVIVO plc Venn Life Sciences - part of hVIVO plc is an Integrated Drug Development partner offering an unique combination of drug development consultancy, clinical trial design and execution, enabling us to create, plan and execute drug development programmes effectively for our customers. Venn’s capabilities and expertise includes: CMC, Non-Clinical, Clinical Development and Regulatory Affairs. With our independent position we can design an optimal program including risk assessment and mitigation, saving time and money whilst achieving project milestone objectives. Visit our website - www.vennlifesciences.com for more information. Drug Substance … Type: | 4 | 1 | 2 | 113 |
 | IDbyDNA Precise Insights for Better Health Delivering on our promise to identify any microbe, from any sample, anywhere in the world will take a team of dedicated, passionate, and experienced individuals. The members of our team at IDbyDNA have a strong track record of building successful organizations and bring a breadth of multi-disciplinary experience including; microbial genomics, bioinformatics, software engineering, laboratory medicine, and commercialization. In concert with the global community of researchers, clinicians, industry partners and policy makers, we will revolutionize microbial detection and bring new solutions to solve problems that are not currently addressable with today’s technologies. Type: | 4 | 0 | 4 | 27 |
 | Roka Furadada Smart active ingredients, safer sun exposure Catalonia Exponential Leader 2023 Roka Furadada’s mission is to reduce the incidence of skin cancer through research, development and production of active ingredients and medical devices, with high efficiency and low toxicologic and environmental impact OUR PURPOSE Roka Furadada wants to help to prevent and reduce the incidence of skin cancer. HOW ARE WE GOING TO DO IT? Developing the first intelligent ultra violet radiation filter: SMART UV, with new molecules that entail therapeutic activity to prevent and treat diseases associated with sun exposure. Cosmetics, Raw Materials , Ingredients, Cosmetic Ingredients, Sunscreen, Sun protection … Type: | 9 | 1 | 6 | 21 |
 | Gnosis by Lesaffre Using what's alive so that we can thrive We are experts in biotransformation processes like fermentation and we cultivate actives ingredients, probiotics, nutritional and functional yeasts that benefit human health and wellbeing. We collaborate with pharmaceutical and nutraceutical brands and industries, including dietary supplements and functional foods&beverages, to develop game-changing products. We harness the power of microorganisms to produce bioactive ingredients, as Vitamin K2, SAMe, Active Folate, S.boulardii and more over to improve human health. We draw on our focused research and development capabilities, rigorous quality and regulatory standards, and extensive clinical validation procedures so that we can develop effective … Type: | 1 | 1 | 0 | 276 |
 | Dendris [Automatic translation follows] Molecular Diagnosis Dendris is a start-up exploiting an innovative technology for the design of biochips. The Dendris technology is based on a patented surface chemistry from dendrimers and on a syndromic approach from a multiplex PCR. The data analysis is carried out using dedicated software based on a statistical learning method constantly enriched by new data. This device allows to quickly obtain a diagnosis for medical, environmental and food applications. molecular biology, in vitro diagnostics, Artificial Intelligence, and Dendrimers Type: | 1 | 1 | 0 | 7 |
 | Tafalgie Therapeutics [Automatic translation follows] Research contributing to health and well-being: innovative polypeptides for the prevention & treatment of pain Tafalgie Therapeutics is a spin-off company of CNRS and AMU engaged in biopharmaceutical research and committed to the development of a new scientific approach for next-generation treatments based on a breakthrough innovation: a mechanism of action derived from an endogenous secreted protein capable of modulating pain signals. Tafalgie Therapeutics aims to become the leading player in the field of pain, by designing and proposing new pharmaceutical active ingredients based on the development of polypeptides derived from TAFA4. At Tafalgie Therapeutics, we aim … Type: | 33 | 10 | 9 | 15 |
 | ExAdEx-Innov Beyond fat cells, the Real Human Fat Tissue Unique R&D platform of donor-derived real human adipose tissue ex vivo for pharmaceutical drug development (obesity, chronic metabolic diseases), dermo-cosmetic, nutraceutical, aesthetic and reconstructive surgery research. ExAdEx-Innov owns exclusive worldwide rights to ExAdEx patented breakthrough technology from French academic laboratories of excellence (Côte d’Azur University, Institut de Biologie Valrose, CNRS, INSERM, University Hospital of Nice) and is supported by SATT Sud-Est, IdEX Université Côte d'Azur, CNRS Innovation, Provence Côte d'Azur Business Incubator, Métropôle Nice Côte d’Azur and Eurobiomed Healthtech Accelerator. adipose tissue, cosmetic testing, research platform, in vitro, ex vivo, models, obesity, … Type: | 19 | 9 | 12 | 6 |
 | Epsidy Empowering clinical science Born from an electric impulse, with smart connectivity and mindful technology, we empower clinical scientists in the fight against cardiovascular diseases. Yet, the best research and diagnostic tool, Magnetic Resonance Imaging (MRI) is used too rarely, and too often as a last resort when other techniques fail. Epsidy is addressing technological and practical issues with cardiac MRI. Epsidy is a start-up co-founded by engineers and PhDs, with a solid scientific culture and decades of combined experience. Epsidy focuses on the development of MRI-compatible instrumentation for better diagnosis and more effective therapy. Epsidy core values are ownership, trust, … Type: | 5 | 2 | 3 | 5 |
 | NeoVentures Biotechnology Europe Aptamarker Platform | High-Plex Proteomics | Biomarker Discovery | Advanced DNA Aptamer Library & Machine Learning At NeoVentures Biotechnology Europe we are committed to revolutionizing the biopharmaceutical field through a cutting-edge biomarker discovery platform, propelling the industry towards personalized medicine with rapid, cost-effective, and automated processes for biomarker discovery and validation. Our Aptamarker platform leverages a library of 16.8 million DNA aptamers to analyze epitope profiles in biofluids, liquid biopsy or tissue, facilitating the precise measurement of surrogate biomarkers and expediting the creation of predictive In Vitro Diagnostic (IVD) tests tailored to distinct pathophysiological conditions. With our advanced DNA aptamer … Type: | 1 | 1 | 0 | 4 |
 | Advesya Transforming cancer and autoimmune treatments with unique IL-1RAP targeting approaches Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers. Haematology & Oncology, Antibody Drug Conjugate, Cell Therapy, and Autoimmune Type: | 7 | 2 | 1 | 24 |
 | LYMPHOBANK [Automatic translation follows] Ready-to-use cell bank, for research, for patients Lymphobank - ready-to-use cell bank, for research, for patients. Lymphobank is a biotech company specializing in the supply of adult and placental blood cells for research use, the characteristics of which will be available online (www.lymphobank.fr), allowing the choice of the cell product according to a donor of interest. Our services are focused on the development of cellular immunotherapy products. In addition, Lymphobank is developing an innovative approach to allogeneic adoptive immunotherapy for hepatocellular carcinoma (the most common liver cancer and the second leading cause of cancer-related death worldwide, with … Type: | 4 | 2 | 2 | 4 |
 | Genvade Therapeutics Dedicated to developing treatments for rare diseases originated from nonsense mutations Genvade aims to harness the power of nonsense mutation readthrough molecules to develop treatments for some of the most burdensome rare diseases. Our lead compound targets indications include cystic fibrosis, Duchenne muscular dystrophy and other genetic diseases. small molecules, drug discovery and development, rare diseases, nonsense mutation corrector, cystic fibrosis, genetic diseases, oncology, readthrough, and Duchenne Type: | 2 | 2 | 0 | N/A |
 | Seenel Imaging Seenel Imaging is dedicated to functional Neuroimaging technology. We launched in 2019 a breakthrough research device combining EEG & fNIRS further to 10 years of Academic research. Medelopt® is a wearable High Resolution NIRS/EEG device with unique features on the market. NIRS, EEG, Brain Imaging, Functional NIRS, Cognitive Research, Optical Imaging, Innovation, and Neuroscience Type: | 2 | 2 | 0 | 8 |
 | TheraSonic Enabling drug delivery to the brain. TheraSonic is revolutionizing the treatment of brain diseases by enhancing non-invasive drug delivery to the brain using focused ultrasound technology. Our innovative approach aims to transform neurological care and improve patient outcomes. --- TheraSonic révolutionne le traitement des maladies cérébrales en améliorant la délivrance de médicaments dans le cerveau grâce à des ultrasons focalisés non-invasifs. Notre approche innovante vise à transformer les soins neurologiques et à améliorer les résultats pour les patients. Type: | 14 | 7 | 9 | 6 |
 | IOME BIO Harnessing unique, proprietary microbiome insights to unlock the efficacy of immuno-oncology Cancer continues to be a leading cause of disability and early mortality worldwide. Immune checkpoint blockade with PD/L-1 therapies such as Keytruda and Opdivo can induce complete and durable clinical responses in multiple tumors, a breakthrough in cancer treatment over the last decade. However, only around 20% of patients respond and many trials have failed Many R&D programs in multiple companies are attempting to improve the clinical efficacy of PD/L-1 therapies, but no solution is yet approved. Most of these approaches target T-cells or the tumour microenvironment. Patients with … Type: | 5 | 2 | 4 | 4 |
 | CALNESIS Your physical chemistry laboratory CALNESIS is an independent laboratory specializing in Physical Chemistry. Physical chemistry is involved wherever there is matter...and sometimes where there isn't! We work for a wide range of customers in a variety of fields: chemicals, petrochemicals, pharmaceuticals, food, energy, transport, space, etc. We carry out R&D studies, measurements and analyses, particularly in the fields of thermal analysis, calorimetry, rheology, analytical chemistry, thermal properties, interfaces, mechanical testing, safety data, etc. But that's not all! We also design, develop and manufacture specific measurement benches to your specifications, with control and monitoring software tailored to the application in question! … Type: | 0 | 0 | 0 | 4 |
 | Defymed Advanced therapies inspired for you Defymed is a French SME that develops innovative medical devices aimed at treating patients physiologically in order to improve the clinical effectiveness of their treatment as well as their comfort. Defymed is a spin-off of the Centre européen d’étude du Diabète (European center for diabetes studies), which began work on a bioartificial pancreas in 1996. Today, Defymed focuses on diabetes, which is considered to be one of the major epidemics of the 21st century. There are currently two medical devices being developed by Defymed which are at an advanced preclinical trial phase: - #MailPan®: bioartificial … Type: | 28 | 7 | 24 | 3 |
 | TISSIUM Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully … Tags: FrenchTech120 Type: | 17 | 11 | 6 | 129 |
Startup